Malaria Treatment Market Key Players, Share, Size, Trends, Aftermarket, Growth, Opportunities, and Regional Forecast To 2030

The malaria treatment market was valued at US$ 3,296.98 million in 2022 and is expected to reach US$ 24,487.73 million by 2030; it is estimated to grow at a CAGR of 28.5% from 2022 to 2030.

Market Insights and Analyst View :

Malaria is a life-threatening infectious disease caused by the Plasmodium parasite. The market for malaria treatment is growing due to the high prevalence of malaria in low-income countries and global malaria elimination programs initiated by international and national organizations. Also, the increasing launch of advanced diagnostic tools and rising research activities to provide effective therapeutics are driving the growth of the malaria treatment market. Over the two peak years of the pandemic (2020-2021), COVID-related disruptions led to more than 13 million malaria cases and 63,000 associated deaths. The WHO African Region continues to hold a disproportionately huge share of the global malaria burden. In 2021, Africa was home to approximately 95% of all malaria cases and 96% of deaths. Furthermore, children under 5 years of age accounted for ~80% of all malaria deaths in the region. According to the same source, Nigeria, Democratic Republic of the Congo, the United Republic of Tanzania, and Niger accounted for over half of all malaria deaths worldwide.

Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00018229?utm_source=OpenPR&utm_medium=10860

Key Players Analysis :

• Cipla Ltd
• Pfizer Inc
• Sun Pharmaceutical Industries Ltd
• Sanofi SA.
• GSK Plc
• Novartis AG
• Pfizer Inc
• AdvaCare Pharma USA LLC
• VLP Therapeutics LLC

Report Segmentation and Scope :

Based on treatment, the malaria treatment market is segmented into generic drugs, originators, vaccines, and others. Based on route of administration, the malaria treatment market is divided into oral and parenteral. Based on distribution channel, the malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. By geography, the malaria treatment market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, Kenya, Tanzania, Rwanda, Nigeria, Ghana, Uganda, Angola, Cameroon, Senegal, Zambia, and Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

Segmental Analysis :

Based on treatment, the malaria treatment market is segmented into generic drugs, originators, vaccines, and others. In 2022, the vaccines segment held the largest share of the market. Also, the segment is expected to record the highest CAGR during the forecast period. Vaccines provide active acquired immunity against particular infectious diseases. The market for malaria vaccines is growing at a significant growth rate owing to increasing research and development activities and an increasing pipeline of vaccine candidates. The only approved malaria vaccine is RTS,S vaccine developed by GlaxoSmithKline to prevent the Plasmodium falciparum malaria parasite from entering the liver. It requires four injections and is being provided to young children through national immunization programs in sub-Saharan African countries. The vaccine is being given as part of a pilot introduction that began in 2019. International and local cooperation has been integral in the development of the vaccine, and by the end of the pilot roll-out in 2024; funding for RTS,S is estimated to exceed US$ 1 billion, out of which US$ 700 million will be provided by GSK, which has donated 10 million doses for the pilot.

Get Full Copy of This Report @ https://www.theinsightpartners.com/buy/TIPRE00018229?utm_source=OpenPR&utm_medium=10860

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Malaria Treatment Market based on various segments. It also provides market size and forecast with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Malaria Treatment Market by each region is later sub-segmented by respective countries and segments.

Contact US
Contact Person : Ankit Mathur
Phone : +1-646-491-9876
E-mail : sales@theinsightpartners.com

About US
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.

This release was published on openPR.